삼성서울병원

Ko En

Seol, Ho Jun M.D

TITLE
Professor, Department of neurosurgery, Samsung Medical Center, Sungkyunkwan university School of Medicine
Treament Schedule 07 月
DATE
MON
01
TUE
02
WEB
03
THU
04
FRI
05
SAT
06
SUN
07
MON
08
TUE
09
WEB
10
THU
11
FRI
12
SAT
13
SUN
14
MON
15
TUE
16
WEB
17
THU
18
FRI
19
SAT
20
SUN
21
MON
22
TUE
23
WEB
24
THU
25
FRI
26
SAT
27
SUN
28
MON
29
TUE
30
WEB
31
AM
PM
Treament Schedule 08 月
DATE
THU
01
FRI
02
SAT
03
SUN
04
MON
05
TUE
06
WEB
07
THU
08
FRI
09
SAT
10
SUN
11
MON
12
TUE
13
WEB
14
THU
15
FRI
16
SAT
17
SUN
18
MON
19
TUE
20
WEB
21
THU
22
FRI
23
SAT
24
SUN
25
MON
26
TUE
27
WEB
28
THU
29
FRI
30
SAT
31
AM
PM

Medical School

Seoul National University College of Medicine

Specialty Training

Fellowship   Brain tumor & stereotactic surgery, Seoul National University Hospital
Labatt Brain Tumor Research Center, Toronto University, Hospital for Sick Children, Canada
Residency   Seoul National University Hospital
Internship   Seoul National University Hospital

Other Education

Labatt Brain Tumor Research Center, Hospital for Sick Children, University of Toronto, Canada

Participation in Academic Societies
and Research

Executive secretary for Korean Brain Tumor Society
Member of Korean Society of Neuro-Oncology
Member of Korean Society of Pediatric Neurosurgery
Member of Korean Brain Tumor Society

Selected Publications

  • Nat Genet. 2017 Apr;49(4):594-599. doi: 10.1038/ng.3806. Epub 2017 Mar 6. Spatiotemporal genomic architecture informs precision oncology in glioblastoma Lee JK11,2, Wang J3,4,5, Sa JK1,2,6, Ladewig E3,4, Lee HO7, Lee IH1,2, Kang HJ1,2, Rosenbloom DS3,4, Camara PG3,4, Liu Z3,4, van Nieuwenhuizen P3,4, Jung SW1,2,6, Choi SW1,2,6, Kim J1,2, Chen A3,4, Kim KT7, Shin S1,2,6, Seo YJ1,2, Oh JM1,2, Shin YJ1,2,7, Park CK8, Kong DS2, Seol HJ2, Blumberg A9, Lee JI2, Iavarone A10,11,12, Park WY6,7, Rabadan R3,4, Nam DH1,2,6.
    View PubMed
  • Cancer Res Treat. 2017 Jan;49(1):193-203. doi: 10.4143/crt.2015.473. Epub 2016 Jun 27. Concurrent Chemoradiotherapy with Temozolomide Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients: A Retrospective Multicenter Observation Study in Korea Kim BS11, Seol HJ2, Nam DH2, Park CK3, Kim IH4, Kim TM5, Kim JH6, Cho YH6, Yoon SM7, Chang JH8, Kang SG8, Kim EH8, Suh CO9, Jung TY10, Lee KH11, Kim CY12, Kim IA13, Hong CK14, Yoo H15, Kim JH16, Kang SH17, Kang MK18, Kim EY19, Kim SH20, Chung DS21, Hwang SC22, Song JH23, Cho SJ24, Lee SI25, Lee YS26, Ahn KJ27, Kim SH28, Lim DH29, Gwak HS30, Lee SH31, Hong YK32.
    View PubMed
  • J Clin Neurosci. 2017 Jan;35:35-41. doi: 10.1016/j.jocn.2016.10.002. Epub 2016 Oct 18. Gamma knife radiosurgery for residual or recurrent intracranial hemangiopericytomas Kim BS11, Kong DS2, Seol HJ2, Nam DH2, Lee JI3.
    View PubMed
  • J Korean Neurosurg Soc. 2017 Jan 1;60(1):21-29. doi: 10.3340/jkns.2016.0404.005. Epub 2016 Dec 29. The Influence of Biomarker Mutations and Systemic Treatment on Cerebral Metastases from NSCLC Treated with Radiosurgery Lee MH11, Kong DS1, Seol HJ1, Nam DH1, Lee JI1.
    View PubMed
  • Cancer Med. 2016 Dec;5(12):3615-3621. doi: 10.1002/cam4.955. Epub 2016 Nov 23. Analysis of risk factors to predict communicating hydrocephalus following gamma knife radiosurgery for intracranial schwannoma Lee S11, Seo SW2, Hwang J1, Seol HJ1, Nam DH1, Lee JI1, Kong DS1.
    View PubMed